We are live on ! Find out more
EEG

E.E. Geduld Portfolio holdings

AUM $178M Turnover 52.78%
1-Year Est. Return 29.34%
This Fund
S&P 500
This Quarter Est. Return
+15.78%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$178M
AUM Growth
+$77.6M
Cap. Flow
-$471K
Cap. Flow %
-0.26%
Top 10 Hldgs %
77.6%
Holding
252
New
61
Increased
18
Reduced
33
Closed
72
Avg Time Held Equity + Options
1 year
Top 10 Avg Time Held Equity + Options
0.6 years
Top 20 Avg Time Held Equity + Options
0.6 years
Avg Time Held Equity only
1 year
Top 10 Avg Time Held Equity only
0.8 years
Top 20 Avg Time Held Equity only
0.7 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 47.75%
2 Financials 33.86%
3 Healthcare 7.1%
4 Technology 4%
5 Consumer Discretionary 2.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
VG icon
101
DELISTED
Vonage Holdings Corporation
VG
$69K 0.04%
10,000
-10,000
-50% -$66.2K
2016 Q3
1 quarter
ASB.WS icon
102
DELISTED
Associated Banc-Corp Warrants
ASB.WS
$64K 0.04%
11,000
-6,000
-35% -$25.1K
2013 Q2
14 quarters
AWRE icon
103
Aware
AWRE
$20.7M
$61K 0.03%
10,000
– –
2013 Q4
12 quarters
QURE icon
104
uniQure
QURE
$1.55B
$56K 0.03%
+10,000
New +$67.1K
2016 Q4
0 quarters
LPCN icon
105
Lipocine
LPCN
$12.8M
$55K 0.03%
882
-883
-50% -$55.9K
2016 Q2
2 quarters
HCACW icon
106
DELISTED
Hennessy Capital Acquisition Corp. II
HCACW
$55K 0.03%
65,000
+1,900
+3% +$623
2016 Q2
2 quarters
TCRT icon
107
Alaunos Therapeutics
TCRT
$7.95M
$54K 0.03%
67
– –
2016 Q3
1 quarter
HGT
108
DELISTED
Hugoton Royalty Trust
HGT
$54K 0.03%
25,000
– –
2016 Q2
2 quarters
TCF.WS
109
DELISTED
TCF Financial Corporation
TCF.WS
$53K 0.03%
15,100
– –
2013 Q2
14 quarters
MNKD icon
110
MannKind Corp
MNKD
$997M
$48K 0.03%
15,000
– –
2016 Q3
1 quarter
PRSO icon
111
Peraso
PRSO
$5.9M
$46K 0.03%
+25
New +$98.5K
2016 Q4
0 quarters
VNCE icon
112
Vince Holding Corp
VNCE
$156M
$41K 0.02%
1,000
-1,000
-50% -$47.7K
2016 Q3
1 quarter
ROX
113
DELISTED
Castle Brands, Inc.
ROX
$38K 0.02%
50,000
– –
2013 Q2
14 quarters
GCVRZ
114
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$38K 0.02%
100,000
-25,000
-20% -$8.46K
2013 Q2
14 quarters
CRIS icon
115
Curis
CRIS
$907K
$31K 0.02%
5
– –
2013 Q2
14 quarters
FBIO icon
116
Fortress Biotech
FBIO
$61.7M
$27K 0.02%
667
– –
2013 Q2
14 quarters
CGRN
117
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$20K 0.01%
3,000
– –
2016 Q3
1 quarter
CNTF
118
DELISTED
China TechFaith Wireless Communication Technology Ltd
CNTF
$19K 0.01%
10,000
– –
2016 Q1
3 quarters
NXEOW
119
DELISTED
Nexeo Solutions, Inc. Warrant
NXEOW
$19K 0.01%
27,000
-7,992
-23% -$4.64K
2016 Q2
2 quarters
LCAHW
120
DELISTED
Landcadia Holdings, Inc. Warrant
LCAHW
$18K 0.01%
+25,000
New +$15.4K
2016 Q4
0 quarters
INNL
121
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
$15K 0.01%
21,506
-5,000
-19% -$18.6K
2016 Q1
3 quarters
ELECW
122
DELISTED
Electrum Special Acquisition Corporation
ELECW
$14K 0.01%
50,000
– –
2015 Q4
4 quarters
KLREW
123
DELISTED
KLR Energy Acquisition Corp.
KLREW
$14K 0.01%
+10,000
New +$5.84K
2016 Q4
0 quarters
DXTR
124
DELISTED
Dextera Surgical Inc.
DXTR
$13K 0.01%
13,400
– –
2016 Q2
2 quarters
EMIS
125
DELISTED
EMISPHERE TECHNOLOGIES INC
EMIS
$12K 0.01%
20,000
– –
2013 Q2
14 quarters

Similar funds

E.E. Geduld's Q4 2016 Portfolio in Review

As of Q4 2016, E.E. Geduld held 252 positions worth $178M, up 77% from $100M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

E.E. Geduld's Q4 2016 filing shows 61 new, 18 increased, 33 reduced and 72 closed positions. Its largest new stake was Salesforce: 25,000 shares worth $1.71M. The largest sale was Broadcom, an estimated $863K.

By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • E.E. Geduld's largest Q4 2016 buy was Salesforce: 25,000 shares worth $1.71M.
  • E.E. Geduld added most to Amazon in Q4 2016, an estimated $1.57M increase.
  • E.E. Geduld's biggest Q4 2016 reduction was Sarepta Therapeutics, cutting an estimated $778K.
  • E.E. Geduld fully exited Broadcom in Q4 2016, selling an estimated $863K.
  • E.E. Geduld's ten largest holdings make up 78% of its $178M portfolio in Q4 2016.
  • E.E. Geduld opened 61 new positions and closed 72 in Q4 2016.
  • E.E. Geduld's portfolio value rose 77% quarter-over-quarter to $178M.

Based on E.E. Geduld's 13F filing for Q4 2016, filed 8 Feb 2017.